Tag Archive 'antihipertensivos'

Martes 11 / junio / 2013

Adherence of Patients to the Antihypertensive Treatment in Georgian Population

Filed under: comentario — Mario Hernández Cueto — junio 11th, 2013 — 10:07

Adherence of Patients to the Antihypertensive Treatment in Georgian Population

ComentandoPor: D. Trapaidze MD., B. Tsinamdzgvrishvili MD, PhD., R. Tataradze MD, PhD., L. Sturua MD, PhD, MPH., T. Abesadze MD.y A. Rekhviashvili MD.  6VCC > High Blood Pressure. (September – November/2009)

Hypertension is a common, chronic disorder which is associated with a significant risk for cardiovascular diseases. Current guidelines emphasise that lowering elevated blood pressure (BP) reduced morbidity from stroke, myocardial infarction, congestive heart failure and renal failure. This inadequate control not only has significant consequences in terms of patient morbidity and mortality, but also in terms of health care costs.
Poor compliance with antihypertensive therapy is thought to be a major factor in the failure to control hypertension. Between 30% and 46% of patients may be non compliant with their antihypertensive drug regimens.
There has been much debate concerning the causes of noncompliance with antihypertensive therapy. Major factors are thought to be asymptomatic nature of hypertension, unacceptable side effects of therapy, suboptimal antihypertensive efficacy, and lack of effective communication between clinician and patient. [Actualizado: 11 de junio de 2013]

Comentarios desactivados

Lunes 20 / mayo / 2013

The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review

Filed under: Revisiones — Mario Hernández Cueto — mayo 20th, 2013 — 11:27

The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review

Hypertension Reasearch JournalPor: Anastasia G Ptinopoulou, Maria I Pikilidou y Anastasios N Lasaridis.  Hypertension Research (2013) 36, 91–101.

Data from randomized clinical trials and epidemiological evidence identify systemic hypertension as the second most common modifiable risk factor for chronic kidney disease (CKD) progression after diabetes mellitus. CKD may progress silently over the years and early diagnosis and control of hypertension is of major importance in delaying renal function decline. Recent guidelines for the treatment of hypertension suggest the use of a variety of antihypertensive drugs in order to achieve the desired blood pressure levels. Renin–angiotensin system inhibitors have been undoubtedly studied the most and are suggested by guidelines and experts as first choice in patients with hypertension and renal injury, particularly in those with diabetes, as they have repeatedly shown to significantly reduce proteinuria. [Actualizado: 20 de mayo 2013]

Comentarios desactivados

Martes 18 / septiembre / 2012

The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition

Filed under: Revisiones — Mario Hernández Cueto — septiembre 18th, 2012 — 8:31

The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition

BMC GeriatricsPor: Ihab Hajjar, Meaghan Hart, William Milberg, Vera Novak, y Lewis Lipsitz. BMC Geriatrics 2009, 9:48.

Nuestro objetivo es llevar a cabo un estudio doble ciego aleatorizado ensayo clínico controlado con antihipertensivos y función vascular endotelial y cognitiva (AVEC), para comparar un tratamiento de 3 años con antihipertensivos (lisinopril, candesartán o hidroclorotiazida) y su efecto sobre la memoria y la función ejecutiva, el flujo sanguíneo cerebral y la función endotelial centro de personas mayores con hipertensión arterial y pruebas objetivas precoz de las deficiencias ejecutivas o de memoria.

Comentarios desactivados

Miércoles 5 / septiembre / 2012

Antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability

Filed under: investigaciones — Mario Hernández Cueto — septiembre 5th, 2012 — 7:46

Investigaciones expone trabajos que pueden aún no tener evidencias suficientes por su actualidad.

Antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability

InvestigacionesPor: Ji Young Park, Jung Wook Yun, Young Whan Choi, Jin Ung Bae, Kyo Won Seo, Seung Jin Lee, So Youn Park, Ki Whan Hong y Chi Dae Kim. Hypertension Research (2012) 35, 928–934.

These alterations in BP, NOS phosphorylation and ROS production in the vasculature of Ang II-treated mice were markedly and dose-dependently reversed by simultaneous administration of GA (2 and 10μg kg−1 per min). In addition, Ang II-induced ROS production in cultured vascular cells such as endothelial cells and vascular smooth muscle cells was markedly attenuated by GA. These results suggested that GA attenuated the increase in BP via preservation of vascular NO bioavailability not only by inhibiting ROS production but also by preventing the impairment of eNOS function in the vasculature of Ang II-induced hypertensive mice.

Comentarios desactivados

Older Posts »